Dynamics of the pneumococcal population causing acute exacerbations in COPD patients in a Barcelona hospital (2009-12): Comparison with 2001-04 and 2005-08 periods

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 932-939

  Domenech, Arnau ^a,b   Ardanuy, Carmen ^a,b   Tercero, Anais ^a,b   García Somoza, Dolors ^a,b   Santos, Salud ^b,c   Liñares, Josefina ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Conjugate vaccines; Genotype; Serotype; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

AGED; AIRWAY OBSTRUCTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HISTORICAL PERIOD; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PNEUMOCOCCAL INFECTION; POPULATION; SEROTYPE; VACCINATION;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CONJUGATE VACCINES; GENOTYPE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 84896471485     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt476     Document Type: Article

References (25)

1. World Health Organization. Chronic Obstructive Pulmonary Disease. 2012. http://www.who.int/mediacentre/factsheets/fs315/en (12 January 2013, date last accessed).
2. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31.
3. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-65.
4. Calix JJ, Porambo RJ, Brady AM et al. Biochemical, genetic, andserological characterization of two capsule subtypesamong Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 2012; 287: 27885-94.
5. Walters JA, Smith S, Poole P et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010; issue 11: CD001390.
6. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-46.
7. Lexau CA, Lynfield R, Danila R et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294: 2043-51.
8. Kyaw MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354: 1455-63. [Erratum in: N Engl J Med 2006; 355: 638]
9. Vila Córcoles A, Ochoa Gondar O, Gutiérrez Pérez A et al. Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011. Rev Esp Salud Publica 2012; 86: 637-43.
10. Domenech A, Ardanuy C, Calatayud L et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 2011; 66: 487-93.
11. Pauwels RA, Buist AS, Calverley PM et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. AmJ Respir Crit Care Med 2001; 163: 1256-76.
12. Centers for Disease Control and Prevention. PCR Deduction of Pneumococcal Serotypes. http://www.cdc.gov/ncidod/biotech/strep/pcr.htm (4 February 2013, date last accessed).
13. Fenoll A, Aguilar L, Vicioso MD et al. Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleuralfluidin Spain from 1997 to 2008. Antimicrob Agents Chemother 2010; 54: 5387-90.
14. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-60.
15. Vila-Corcoles A, Ochoa-Gondar O. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Expert Rev Vaccines 2012; 11: 221-36.
16. Hernandez-Bou S, Garcia-Garcia JJ, Gene A et al. Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona. Diagn Microbiol Infect Dis 2012; 74: 258-62.
17. Rodrigues F, Foster D, Caramelo F et al. Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity. Vaccine 2012; 30: 3951-6.
18. Ardanuy C, Tubau F, Pallares R et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009; 48: 57-64.
19. Fenoll A, Aguilar L, Giménez MJ et al. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain. Int J Antimicrob Agents 2012; 40: 18-23.
20. Moore MR, Gertz RE Jr, Woodbury RL et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197: 1016-27.
21. Ardanuy C, Rolo D, Fenoll A et al. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 2009; 64: 507-10.
22. Richter SS, Heilmann KP, Dohrn CL et al. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg Infect Dis 2013; 19: 1074-83.
23. Ardanuy C, Marimón JM, Calatayud L et al. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One 2012; 7: e43619.
24. Llor C, Cots JM, Gaspar MJ et al. Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening. Eur J Clin Microbiol Infect Dis 2009; 28: 893-7.
25. Campanyes d'antibiòtics i dades de consum en primària a Catalunya. http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/Professionals/Recursos/Butlletins_de_salut/PROMOCIO_I_PROTECCIO_DE_ LA_SALUT/BEC_Butlleti_epidemiologic_de_Catalunya/2012/Arxius/bec_marc_ 2012.pdf (17 May 2013, date last accessed).